Article Details

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon - Newsdrum

Retrieved on: 2023-01-07 21:22:37

Tags for this article:

Click the tags to see associated articles and topics

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon - Newsdrum. View article details on hiswai:

Excerpt

Biotechnology major Biocon on Saturday said the US health regulator has issued a complete response letter for Biocon Biologics' application for ...

Article found on: www.newsdrum.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up